PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 92 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,387,000 | +2452.1% | 539,571 | +1743.7% | 2.06% | +1663.2% |
| Q2 2016 | $407,000 | -91.2% | 29,266 | -90.4% | 0.12% | -93.0% |
| Q1 2016 | $4,634,000 | -31.3% | 305,459 | -14.1% | 1.66% | -41.2% |
| Q4 2015 | $6,743,000 | -21.8% | 355,459 | -21.7% | 2.83% | -17.0% |
| Q3 2015 | $8,624,000 | -19.4% | 453,878 | +9.3% | 3.41% | -18.2% |
| Q2 2015 | $10,703,000 | – | 415,338 | – | 4.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |